In vivo imaging models of bone and brain metastases and pleural carcinomatosis with a novel human EML4-ALK lung cancer cell line

EML4-ALK lung cancer accounts for approximately 3–7% of non-small-cell lung cancer cases. To investigate the molecular mechanism underlying tumor progression and targeted drug sensitivity/resistance in EML4-ALK lung cancer, clinically relevant animal models are indispensable. In this study, we found...

Descripción completa

Detalles Bibliográficos
Autores principales: Nanjo, Shigeki, Nakagawa, Takayuki, Takeuchi, Shinji, Kita, Kenji, Fukuda, Koji, Nakada, Mitsutoshi, Uehara, Hisanori, Nishihara, Hiroshi, Hara, Eiji, Uramoto, Hidetaka, Tanaka, Fumihiro, Yano, Seiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376432/
https://www.ncbi.nlm.nih.gov/pubmed/25581823
http://dx.doi.org/10.1111/cas.12600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376432/
https://www.ncbi.nlm.nih.gov/pubmed/25581823
http://dx.doi.org/10.1111/cas.12600

Ejemplares similares